Methods for treatment of muscular dystrophy
AssigneeFibroGen, Inc.
InventorsEnrique Brandan, Roel Goldschmeding, Noelynn A. Oliver
Life of this patent
Estimating the term…
Abstract
The present invention relates to methods and agents useful for treating muscular dystrophy. Methods and agents for treating various physiological and pathological features associated with muscular dystrophy are also provided.
Claims12
A method for increasing muscle strength in a subject having muscular dystrophy, the method comprising administering to the subject a therapeutically effective amount of an anti-connective tissue growth factor (CTGF) antibody or fragment thereof, thereby increasing muscle strength.
A method for increasing the maximal force or tetanus strength of muscle in a subject having muscular dystrophy, the method comprising administering to the subject a therapeutically effective amount of an anti-CTGF antibody or fragment thereof, thereby increasing the maximal force or tetanus strength of muscle.
Dependencies are inferred from the claim text.